Canadian cannabis firms publicly discuss expansion into hemp‑derived CBD market
Canadian cannabis firms publicly discuss expansion into hemp‑derived CBD market The passage lists statements from CEOs and executives of publicly traded Canadian cannabis companies about their interest in CBD. It provides no concrete financial transactions, illicit activities, or links to high‑level political figures, limiting its investigative value. The information is largely public corporate commentary, offering only low‑level leads for market‑trend monitoring. Key insights: Executives of Aphria, Aurora, Canopy Growth, Cronos, Emblem, and Emerald Health discuss CBD strategies.; Mentions of potential entry into U.S. market and European markets (Portugal, Italy).; Strategic partnership between Emblem and GreenSpace Brands for CBD health and beauty products.
Summary
Canadian cannabis firms publicly discuss expansion into hemp‑derived CBD market The passage lists statements from CEOs and executives of publicly traded Canadian cannabis companies about their interest in CBD. It provides no concrete financial transactions, illicit activities, or links to high‑level political figures, limiting its investigative value. The information is largely public corporate commentary, offering only low‑level leads for market‑trend monitoring. Key insights: Executives of Aphria, Aurora, Canopy Growth, Cronos, Emblem, and Emerald Health discuss CBD strategies.; Mentions of potential entry into U.S. market and European markets (Portugal, Italy).; Strategic partnership between Emblem and GreenSpace Brands for CBD health and beauty products.
Tags
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.